Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24547742 | 0.89 | P2RX4 (0.56) | LMNAHTTMAPTALDH1A1HPGD | |
| SCHEMBL24547658 | 0.88 | LMNA (0.67) | LMNAHTTMAPTALDH1A1HPGD | |
| SCHEMBL24547661 | 0.87 | ABCB1 (0.50) | LMNAHTTMAPTALDH1A1HPGD | |
| SCHEMBL24547656 | 0.86 | ELANE (0.46) | LMNAHTTMAPTALDH1A1HPGD | |
| SCHEMBL24547630 | 0.86 | LMNA (0.48) | LMNAHTTMAPTALDH1A1HPGD | |
| SCHEMBL24547741 | 0.85 | CNR2 (0.49) | LMNAHTTMAPTKMT2AGAA | |
| SCHEMBL24547739 | 0.82 | KMT2A (0.49) | LMNAHTTMAPTALDH1A1HPGD | |
| SCHEMBL24547657 | 0.81 | LMNA (0.44) | LMNAHTTMAPTALDH1A1HPGD | |
| SCHEMBL24547632 | 0.81 | P2RX4 (0.43) | LMNAHTTMAPTALDH1A1HPGD | |
| SCHEMBL24547744 | 0.78 | KDM4E (0.45) | LMNAHTTMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067654-A1 | OXYTOCIN RECEPTOR MODULATORS | Kinoxis Therapeutics Pty Ltd (AU) | 2024-02-29 | — | — | US | disclosed |
| US-20240067654-A1 | OXYTOCIN RECEPTOR MODULATORS | Kinoxis Therapeutics Pty Ltd (AU) | 2024-02-29 | — | — | US | disclosed |
| WO-2022126179-A1 | OXYTOCIN RECEPTOR MODULATORS | THE UNIVERSITY OF SYDNEY (AU) | 2022-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067654-A1 | OXYTOCIN RECEPTOR MODULATORS | OXTR, AVPR1B, AVPR1A | LMNA 2876/4885HTT 2995/4885MAPT 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.